ScreenerHero

TRVNTrevena, Inc.

NAS · US · Healthcare · Biotechnology · trevena.com
0.0010USD0.00%Mkt Cap: 9501 $P/E: —

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Olic…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap9.50K $
Enterprise Value24.10M $
Revenue (TTM)546.00K $
Gross Profit1.46M $
Net Income (TTM)-40.29M $
Revenue/Share0.6850 USD
Last Price0.0010 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.76
EV/Revenue44.14
P/S0.02
P/B-0.00
EPS (TTM)-48.89
EPS (Forward)-19.85
52W Range
0.00100% of range1.501
52W High1.501 USD
52W Low0.0010 USD
Profitability
Gross Margin46.56%
Oper. Margin-1970.67%
EBITDA Margin0.00%
Profit Margin-1289.25%
ROE526.17%
ROA-99.22%
Growth
Revenue Growth57.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-33.03M $
CapEx (TTM)41.00K $
FCF Margin-3081.27%
FCF Yield-177073.47%
Net Debt24.10M $
Net Debt/EBITDA-0.76
Balance Sheet
Debt/Equity-4.73
Current Ratio2.42
Quick Ratio2.21
Book Value/Sh-27.2690 USD
Cash/Share15.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 13, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.863.79K
Float859.07K
Insiders0.48%
Institutions11.08%
Short Interest
Short Ratio1.0d
Short % Float7.03%
Short % Out.6.96%
Shares Short59.36K
Short (prev mo.)16.17K
Technical
SMA 500.0064 (-84.4%)
SMA 2000.0103 (-90.3%)
Beta-0.41
S&P 52W Chg18.16%
Avg Vol (30d)103
Avg Vol (10d)10
Technical Indicators
RSI (14)23.9
MACD-0.0022
MACD Signal-0.0014
MACD Hist.-0.0008
BB Upper0.0167 USD
BB Middle0.0065 USD
BB Lower-0.0037 USD
BB Width314.10%
ATR (14)0.0595 USD
Vol Ratio (20d)0.00x